NEW YORK (GenomeWeb News) – The BloodCenter of Wisconsin is using BioTrove’s genotyping technology to develop a SNP-based screening tool that will help detect rare blood types and make for better transfusion matches, the company said today.
 
The BloodCenter, which provides blood to over 50 hospitals in Wisconsin, is using BioTrove’s OpenArray SNP platform in research that will allow it to stratify blood donors based on genotypic characteristics, which will improve speed and accuracy of transfusion, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.